Tevogen CEO outlines AI expansion and funding in stockholder letter

Go back to Tevogen CEO outlines AI expansion and funding in stockholder letter

Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders

August 1, 2025 3:57 PM EDT

WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Tevogen (Tevogen Bio Holdings Inc. or Company) (Nasdaq: TVGN), today released a letter to stockholders.

Dear Fellow Stockholders,

Tevogen has rapidly evolved from a biotechnology innovator into a dynamic enterprise expanding into artificial intelligence through Tevogen.AI. Our mission remains steadfast:... More